Ranbaxy Laboratories Balance Sheet, Ranbaxy Laboratories Financial Statement & Accounts

YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Balance Sheet - Ranbaxy Laboratories

Ranbaxy Laboratories

BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals

SET ALERT

LIVE

BSE

Feb 10, 17:00

443.30

-8.25 (-1.83%)

VOLUME 80,326

LIVE

NSE

Feb 10, 17:00

442.40

-9.45 (-2.09%)

VOLUME 510,967

SHAREHOLDING PATTERN

Previous Years �

Balance Sheet of Ranbaxy Laboratories

------------------- in Rs. Cr. -------------------

	Dec '10	Dec '09	Dec '08	Dec '07	Dec '06

	12 mths	12 mths	12 mths	12 mths	12 mths

Sources Of Funds
Total Share Capital	210.52	210.21	210.19	186.54	186.34
Equity Share Capital	210.52	210.21	210.19	186.54	186.34
Share Application Money	6.60	175.85	175.66	1.18	0.88
Preference Share Capital	0.00	0.00	0.00	0.00	0.00
Reserves	4,915.28	3,748.54	3,330.92	2,350.68	2,162.79
Revaluation Reserves	0.00	0.00	0.00	0.00	0.00
Networth	5,132.40	4,134.60	3,716.77	2,538.40	2,350.01
Secured Loans	195.39	175.83	162.07	365.07	224.29
Unsecured Loans	4,065.33	3,172.55	3,563.30	3,137.96	2,954.31
Total Debt	4,260.72	3,348.38	3,725.37	3,503.03	3,178.60
Total Liabilities	9,393.12	7,482.98	7,442.14	6,041.43	5,528.61
	Dec '10	Dec '09	Dec '08	Dec '07	Dec '06

	12 mths	12 mths	12 mths	12 mths	12 mths

Application Of Funds
Gross Block	2,857.63	2,620.92	2,386.75	2,261.48	2,133.57
Less: Accum. Depreciation	1,145.52	1,027.52	930.07	791.96	699.54
Net Block	1,712.11	1,593.40	1,456.68	1,469.52	1,434.03
Capital Work in Progress	330.18	414.92	428.77	327.42	301.88
Investments	3,804.44	3,833.69	3,618.03	3,237.55	2,679.95
Inventories	1,489.91	1,230.48	1,198.52	976.07	954.91
Sundry Debtors	1,292.63	1,534.65	1,024.54	882.91	1,013.75
Cash and Bank Balance	22.44	25.56	49.86	69.38	27.06
Total Current Assets	2,804.98	2,790.69	2,272.92	1,928.36	1,995.72
Loans and Advances	1,470.45	1,967.65	2,351.98	882.99	581.18
Fixed Deposits	2,689.85	728.56	1,885.08	111.07	44.09
Total CA, Loans & Advances	6,965.28	5,486.90	6,509.98	2,922.42	2,620.99
Deffered Credit	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2,491.08	3,082.89	3,840.11	1,177.35	985.57
Provisions	927.82	763.03	731.20	738.14	522.67
Total CL & Provisions	3,418.90	3,845.92	4,571.31	1,915.49	1,508.24
Net Current Assets	3,546.38	1,640.98	1,938.67	1,006.93	1,112.75
Miscellaneous Expenses	0.00	0.00	0.00	0.00	0.00
Total Assets	9,393.11	7,482.99	7,442.15	6,041.42	5,528.61

Contingent Liabilities	276.13	261.05	252.85	201.00	159.40
Book Value (Rs)	121.74	94.16	84.24	68.01	63.03



Source : Dion Global Solutions Limited
Explore Ranbaxy Labs connections

Results of Ranbaxy Labs

News
Results
Estimates
Analysis

31.01.2012
Buy Ranbaxy: Sukhani

30.01.2012
Sell Ranbaxy Laboratories; target Rs 355: PINC Research

27.01.2012
No pill for Ranbaxy's pain!

27.01.2012
Sell Ranbaxy Labs; target of Rs 355: PINC Research

More �

Results of Pharmaceuticals Sector

News
Results
Estimates
Analysis

11.02.2012
Buy Glenmark Pharmaceuticals; target Rs 368: Sushil Finance

11.02.2012
Buy Cadila Healthcare; target Rs 854: KRChoksey

11.02.2012
Cipla Q3 PAT likely to grow 32% at Rs 307 cr

11.02.2012
Sun Pharma Q3 PAT seen up 65% at Rs 576 cr

More �

Quick Links for ranbaxylaboratories

Corporate Action
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends

Related Searches ranbaxylaboratories Stock Price, Ranbaxy%20Labs Stock Quote, Ranbaxy%20Labs Results , Ranbaxy%20Labs News .. More »

Follow moneycontrol.com

Explore Moneycontrol

Stocks A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

Mutual Funds A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.